- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05913180
Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries
June 21, 2023 updated by: Tony Bazi, American University of Beirut Medical Center
Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Randomized Double-blinded Controlled Trial
Double-blind placebo-controlled randomized trial aiming to assess the role of Vitamin C supplementation in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Women undergoing Elective GYN surgery are a particularly high-risk group for UTIs, because these operations involve surgery adjacent to the bladder and delayed bladder emptying is common.
It has been estimated that the 'risk of Urinary tract infections among women undergoing elective Gynecologic GYN surgery is between 10-64%, following catheter removal.
Catheterization, in itself, poses a significant risk for UTIs because insertion and removal introduce bacteria and cause trauma, both of which may increase the risk of UTIs.
The incidence of UTI for women in the general population is estimated to be 3-4% per year vs 5% per day of catheterization.
For this reason, multiple interventions have been studied for the prevention of UTIs.
Ascorbic acid (vitamin C) is often suggested as a supplement that can prevent recurrent UTIs by acidification of the urine.
Strong clinical evidence to support this claim in healthy adult women is lacking.
Because of the lack of literature regarding the use of Vitamin C as a prophylactic agent for the prevention of UTIs, the investigators wish to conduct this study to assess the potential therapeutic efficacy of Ascorbic acid in preventing UTIs after elective GYN surgery.
Study Type
Interventional
Enrollment (Estimated)
180
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tony Bazi, M.D.
- Phone Number: 9611350000
- Email: tb04@aub.edu.lb
Study Contact Backup
- Name: George kasyan, M.D.
- Email: g.kasyan@outlook.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Nonpregnant women
- 18 years of age or older
- Undergoing elective GYN surgery
Exclusion Criteria:
- Pregnant women
- Already taking Vitamin C supplementation
- Nephrolithiasis
- Congenital anomaly or neurogenic bladder
- Allergy to ascorbic acid
- On therapeutic anticoagulant medicine during the 6 weeks after surgery
- Gynecological surgery involving fistula repair or a vaginal mesh removal
- Positive Urinalysis in the pre-admission unit
- Recurrent UTIs
- Diabetes
- G6PD
- Hemochromatosis
- Renal disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Vitamin C
1000mg Ascorbic acid daily starting the day of elective gynecological surgery for 10 days
|
1000mg Ascorbic acid orally daily started on the day of elective gynecological surgery for 10 days
Other Names:
|
Placebo Comparator: Placebo
Placebo daily starting the day of elective gynecological surgery for 10 days
|
Placebo tablet daily starting day of elective gynecological surgery for 10 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of UTI
Time Frame: 30 days
|
The Primary endpoint is the proportion of participants who experience a clinically diagnosed and treated UTI as evidenced by a positive urine culture.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Asymptomatic UTI
Time Frame: 30 days
|
The proportion of participants with a positive urine culture, while asymptomatic (asymptomatic bacteriuria) at the end of the study period
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Tony Bazi, M.D., American University of Beirut Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015 Aug;213(2):194.e1-8. doi: 10.1016/j.ajog.2015.04.003. Epub 2015 Apr 13.
- Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86(7):783-7. doi: 10.1080/00016340701273189.
- Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide. 2001 Dec;5(6):580-6. doi: 10.1006/niox.2001.0371.
- Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med. 2004 Apr 26;164(8):842-50. doi: 10.1001/archinte.164.8.842.
- Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011 Jan 1;52(1):23-30. doi: 10.1093/cid/ciq073.
- Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013;15(2):41-8.
- Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg. 2008 Jun;143(6):551-7. doi: 10.1001/archsurg.143.6.551.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 15, 2023
Primary Completion (Estimated)
August 15, 2025
Study Completion (Estimated)
August 15, 2025
Study Registration Dates
First Submitted
June 10, 2023
First Submitted That Met QC Criteria
June 21, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Urologic Diseases
- Disease Attributes
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Infections
- Communicable Diseases
- Urinary Tract Infections
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Protective Agents
- Micronutrients
- Vitamins
- Antioxidants
- Ascorbic Acid
Other Study ID Numbers
- 62/137-H/77-2023-25-2295
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Catheter-Associated Urinary Tract Infection
-
Mayo ClinicCompletedUrinary Tract Infection | Infection Associated With CatheterUnited States
-
Joshua SwanThe Methodist Hospital Research Institute; Texas Southern UniversityCompletedCross Infection | Surgical Wound Infection | Pneumonia, Ventilator-associated | Catheter-related Infections | Infection Due to Indwelling Urinary CatheterUnited States
-
Medline IndustriesCompletedCatheter-Associated Urinary Tract InfectionUnited States
-
American University of Beirut Medical CenterWithdrawnCatheter-Associated Urinary Tract Infection, Ascorbic AcidLebanon
-
Imperial College LondonCompletedSmart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract InfectionCatheter-Associated Urinary Tract InfectionUnited Kingdom
-
Wake Forest University Health SciencesCompletedCatheter-Associated Urinary Tract InfectionUnited States
-
The Cleveland ClinicAmerican Urogynecologic SocietyTerminatedCatheter-Associated Urinary Tract InfectionUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedCatheter-associated Urinary Tract InfectionChina
-
Hospital do CoracaoHospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital Sirio-Libanes and other collaboratorsActive, not recruitingVentilator Associated Pneumonia | Health Care Associated Infection | Catheter-Associated Urinary Tract Infection | Central Line-associated Bloodstream Infection (CLABSI)Brazil
-
Khon Kaen UniversityCompletedCritically Ill Patients | Catheter Associated Urinary Tract InfectionThailand
Clinical Trials on Ascorbic Acid 1000 MG
-
American University of Beirut Medical CenterWithdrawnCatheter-Associated Urinary Tract Infection, Ascorbic AcidLebanon
-
American University of Beirut Medical CenterWithdrawnCatheter-Associated Urinary Tract Infection, Ascorbic AcidLebanon
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR); Sigma Theta Tau International...Completed
-
Pharmacosmos A/SCompletedIron Deficiency Anemia of PregnancyDenmark
-
National Taiwan University Hospital Hsin-Chu BranchCompletedHemodialysis Access Failure
-
Swiss Federal Institute of TechnologyCompletedIron-deficiency | Iron Deficiency AnemiaSwitzerland
-
Ain Shams UniversityCompletedGingival Hyperpigmentaion
-
University of FloridaNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAging | MetabolismUnited States
-
Khon Kaen UniversityNot yet recruitingPregnant Women Diagnosed With Threatened Preterm Labor
-
Terra Biological LLCCompletedPremenstrual Syndrome (PMS)